Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism

Mostrar otras versiones (1)

The spread of SARS-CoV-2 and the increasing mortality rates of COVID-19 create an urgent need for treatments, which are currently lacking. Although vaccines have been approved by the FDA for emergency use in the U.S., patients will continue to require pharmacologic intervention to reduce morbidity a...

Descripción completa

Detalles Bibliográficos
Autores principales: Policard, Martine, Jain, Sidharth, Rego, Samantha, Dakshanamurthy, Sivanesan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163696/
https://www.ncbi.nlm.nih.gov/pubmed/34058265
http://dx.doi.org/10.1016/j.virusres.2021.198464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163696/
https://www.ncbi.nlm.nih.gov/pubmed/34058265
http://dx.doi.org/10.1016/j.virusres.2021.198464

Ejemplares similares